1Department of Neurology, Central Sheffield University Hospitals NHS Trust, UK.
Anticoagulation therapy requires careful risk-benefit assessment, especially in elderly patients or those with comorbidities. Its use is established in atrial fibrillation but not recommended for acute stroke or sinus rhythm secondary prevention.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: